BioWorld Nov 25, 2025 Appointments and advancements for Nov. 24, 2025 #Galvanize Therapeutics #med-tech industry
BioWorld Nov 24, 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed